DEA Commences Hearing on Marijuana Rescheduling Proposal

The U.S. Drug Enforcement Administration has begun formal hearing proceedings to consider reclassifying marijuana from Schedule I to Schedule III of the Controlled Substances Act. This potential change could significantly impact medical research into cannabis and alter patient access to marijuana products. The outcome of these hearings is highly anticipated by various stakeholders.